Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241EnglishN2022August22HealthcarePattern of Use of Non-Steroidal Anti-Inflammtory Drugs in Rural Population, Kerala English0210Annmaria TomEnglish Hima SabuEnglish Kiron S SEnglishAnnmaria Tom, College of Pharmaceutical Sciences, Government Medical College Kannur, Kerala, India. https://doi.org/10.31782/IJMPS.2022.12802Introduction: In India, though studies regarding NSAIDs were conducted, prevalence of its use and its impact on general health is largely lacking. As the prevalence of unmonitored analgesic and NSAID use is rising, it is imperative to assess the pattern of NSAID use and its associated factors. Materials and Methods: This is a cross-sectional, questionnaire-based survey conducted over a period of 6 months in the rural population of Kerala, India. The data was collected with the aid of a Google form. All the data were documented and analysed based on a standard protocol. Results: The prevalence of NSAID use among the 608 participants was found to be 43.4%. The prevalence of regular NSAID use was found to be 17.43%. It was found that females used NSAIDs more than males (49.4%). Regular NSAID use was also found to be higher in the female population (19.9%). Diclofenac (27.6%) and mefenamic acid (24.2%) were the most commonly used NSAIDs. Headache was the major indication (29.9%) for which these drugs were taken. Conclusion: The study analysed the pattern of NSAID use among the rural population of Kerala. The results obtained from the study is indicating to the negligent use of NSAIDs despite being aware of the possible adverse outcomes of its use by the population. This shows that the knowledge about the safe use of NSAIDs is yet to be inculcated in society. EnglishAdverse effect, Analgesic, Attitude, Practice, Prevalence, Regular usehttp://ijcrr.com/abstract.php?article_id=210http://ijcrr.com/article_html.php?did=2101. Antonov K, Isacson D. Prescription and non-prescription analgesic use in Sweden. Ann. Pharmacother.1998;32:485-494 2. Eggen AE. TheTromso study: Frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). J Clin epidemiol.1993;46(11):1297-1304. 3. Ola D, Petter CB, Olav Magnus SF, Milada M, Pål R, Svetlana S. Prevalence of use of non-prescription analgesics in Norwegian HUNT 3 population: Impact of general age exercise and prescription of opioids public health.2015;15:461. 4. Giselle S, Amanda KB, Wanli Z, Ingrid-Katharina W, Daniel G, Angelika Schaffrath R, et al. Prevalence trends, patterns and associations of analgesic use in Germany. BMC Pharmacol Toxicol. 2015; 16:28 5. OzlemO, Onur H, Serdar E, Echen B, Mehmet D. Use of analgesics in adults with pain complaints: prevalence and associated factors, Turkey. Rev Saude Publica.2009;43(1):140-146. 6. Yingjun Z, Denise MB, Andrew NF. Trends in the use of aspirin and Nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf .2014; 23: 43–50. 7. PongsomL, Paid T, Pawaris M, Chanikarn T, ChanitaC, Phunlerd Pet al. Prevalence and Associated Factors of Regular Nonsteroidal Anti-inflammatory Drugs used in a Rural Community, Thailand. Glob. J. Health Sci. 2017; 9: No. 9. 8. Report of the core committee for the revision of National list of Essential medicines A compilation made by Central drugs standard Control Organization November 2015 https://cdsco. gov.in/opencms/opencms/en/consumer/Essential-Medicines/ 9. Suparna C, Gur Prasad D, Ganesh K, Amey M, Abhay AP, Sandesh Set al. Cross-sectional study for prevalence of non-steroidal anti-inflammatory drug-induced gastrointestinal, cardiac and renal complications in India: Interim report. Gastroenterol Res.2015;8(3-4):216-221. 10. Somia G, Maria A. Prevalence of prescribing pattern of more than one NSAID in Pakistan. J. Sci. Innov. Res. 2014; 3 (2): 148-154. 11. Andrew TC, Edward LG, Jeffrey AM, Eva SS, Gary CC, Charles SF. Long-term use of aspirin and non-steroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA.2005;294(8):914-23. 12. David PF, Delyth HJ. Reasons for the use of mild analgesics among English students. Pharm World sci.2008; 30:79-85. 13. Domenico M, Alberto V, Maria CS, Elisabetta P, Ambrogio B, Fabrizio De P, et al.Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol. 2004;60: 731–738. 14. Laurence LB, Randa H-Bjorn CK. Goodman and Gilman’s The Pharmacological basis of Therapeutics, 13th Edition. Newyork: Mc Graw Hill Education; 2018. 15. Robert SB, Robert SS, Hui Q, James AB, Bettina O, Kevin H et al. Cardiovascular events associated with Rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med.2005; 352:1092-1102. 16. Nancy AN, Andrew AW, Mark TB, Richard ML, Andreas H, Joel LP, et al. Complications of the COX 2 inhibitors Parecoxib and Valdecoxib after cardiac surgery. NEJM. 2005;352:1081-1091. 17. Tushar KG. Status of Indian women in higher education. J. educ. Pract.2016; 7:34. 18. Roberto A, Marco Z, PuxedduE, Porcella A, Cuzzolin, L, Dolores P et al. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab.2012May1;13(4):474-90. 19. Dana GC. Auburn University Harrison school of pharmacy. Drugs in pregnancy http://pharmacy.auburn.edu/directory/pdf/ dana-carroll.pdf. 20. Gene Radford M, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV et al. Reversible membranous nephropathy associated with the use of non-steroidal anti-inflammatory drugs. JAMA. 1996; 276(6):466-9. 21. Paul PA, William FK. Glomerular and interstitial disease induced by non-steroidal anti-inflammatory drugs. Am. J Nephrol.1984;4:1-6.